ARCHIVES

King Named Lombardi Center Deputy Director; SWOG Needs New Exec; Murphy Leaves St. Jude

This article is from The Cancer Letter archive.

Vol. 14 No. 30 | July 22, 1988

Download PDF Visit The Full Archive

Related Articles

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

In Brief: THOMAS BURKE Stepped Down As Executive Vice President And Physician-In-Chief at MD Anderson Cancer Center To Accept The New Position Of Executive Vice President of the MD Anderson Cancer Network

December 13, 2013

“We Will Move Forward With Bold Expectations,” NCI Director Says

October 2, 1998

No Cancer Letter For Next Two Weeks

August 30, 1991

NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts

April 3, 1998

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010